TY - JOUR
T1 - See no evil, hear no evil, do no evil
T2 - The lessons of immune privilege
AU - Niederkorn, Jerry Y.
N1 - Funding Information:
I dedicate this review to the memory of J.W. Streilein, who contributed substantially to the understanding of immune-privileged sites. Supported by Research to Prevent Blindness.
PY - 2006/4
Y1 - 2006/4
N2 - Immune-mediated inflammation and allograft rejection are greatly reduced in certain organs, a phenomenon called 'immune privilege'. Immune privilege is well developed in three regions of the body: the eye, the brain and the pregnant uterus. Immune-mediated inflammation has devastating consequences in the eye and brain, which have limited capacity for regeneration. Likewise, loss of immune privilege at the maternal-fetal interface culminates in abortion in rodents. However, all three regions share many adaptations that restrict the induction and expression of immune-mediated inflammation. A growing body of evidence from rodent studies suggests that a breakdown in immune privilege contributes to multiple sclerosis, uveitis, corneal allograft rejection and possibly even immune abortion.
AB - Immune-mediated inflammation and allograft rejection are greatly reduced in certain organs, a phenomenon called 'immune privilege'. Immune privilege is well developed in three regions of the body: the eye, the brain and the pregnant uterus. Immune-mediated inflammation has devastating consequences in the eye and brain, which have limited capacity for regeneration. Likewise, loss of immune privilege at the maternal-fetal interface culminates in abortion in rodents. However, all three regions share many adaptations that restrict the induction and expression of immune-mediated inflammation. A growing body of evidence from rodent studies suggests that a breakdown in immune privilege contributes to multiple sclerosis, uveitis, corneal allograft rejection and possibly even immune abortion.
UR - http://www.scopus.com/inward/record.url?scp=33645107513&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33645107513&partnerID=8YFLogxK
U2 - 10.1038/ni1328
DO - 10.1038/ni1328
M3 - Review article
C2 - 16550198
AN - SCOPUS:33645107513
SN - 1529-2908
VL - 7
SP - 354
EP - 359
JO - Nature Immunology
JF - Nature Immunology
IS - 4
ER -